Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5331260 | 0.98 | TMEM97 (0.39) | TMEM97CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL15265879 | 0.96 | CHRM2 (0.36) | TMEM97CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL5897555 | 0.71 | HTR2A (0.32) | CHRM2CHRM4CHRM5CHRM1DRD2 | |
| SCHEMBL6294617 | 0.69 | CHRM3 (0.30) | CHRM2CHRM4CHRM5CHRM1DRD2 | |
| SCHEMBL6290097 | 0.68 | CHRM3 (0.31) | TMEM97CHRM3 | |
| SCHEMBL6294598 | 0.68 | CHRM3 (0.31) | TMEM97CHRM3 | |
| SCHEMBL3923960 | 0.65 | OXTR (0.49) | — | |
| SCHEMBL8200284 | 0.65 | MAPK1 (0.47) | CHRM2CHRM4CHRM5CHRM1DRD2 | |
| SCHEMBL11122795 | 0.65 | OXTR (0.49) | — | |
| SCHEMBL3371963 | 0.65 | CHRM3 (0.30) | CHRM2CHRM4CHRM5CHRM1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3378312-B1 | SUSTAINED RELEASE PHEROMONE PREPARATION | SHINETSU CHEMICAL CO (JP) | 2022-03-02 | — | — | EP | disclosed |
| US-20180271088-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-09-27 | — | — | US | disclosed |
| EP-3378312-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION | Shin-Etsu Chemical Co., Ltd. (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-5837777-A | CATALYTIC ADDITION POLMERIZATION OF ACRYLATE MONOMER, REACTION WITH OTHER MONOMERS FOR MOLDING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-17 | — | — | US | disclosed |
| WO-1993007119-A1 | NOVEL ANTIMALARIAL PEROXIDES AND PROCESSES FOR THEIR PRODUCTION AND USE | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 1993-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180271088-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION | AUP1, SHBG, ADH1A | TMEM97 479/4885CHRM2 327/4885CHRM4 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.